189 related articles for article (PubMed ID: 30387899)
1. Time trends in incidence and mortality of cutaneous melanoma in Germany.
Garbe C; Keim U; Eigentler TK; Amaral T; Katalinic A; Holleczek B; Martus P; Leiter U
J Eur Acad Dermatol Venereol; 2019 Jul; 33(7):1272-1280. PubMed ID: 30387899
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology of cutaneous melanoma and keratinocyte cancer in white populations 1943-2036.
Garbe C; Keim U; Gandini S; Amaral T; Katalinic A; Hollezcek B; Martus P; Flatz L; Leiter U; Whiteman D
Eur J Cancer; 2021 Jul; 152():18-25. PubMed ID: 34062483
[TBL] [Abstract][Full Text] [Related]
3. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
4. The incidence and mortality of cutaneous melanoma in Southern Germany: trends by anatomic site and pathologic characteristics, 1976 to 2003.
Lasithiotakis KG; Leiter U; Gorkievicz R; Eigentler T; Breuninger H; Metzler G; Strobel W; Garbe C
Cancer; 2006 Sep; 107(6):1331-9. PubMed ID: 16909413
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology of cutaneous melanoma and non-melanoma skin cancer in Schleswig-Holstein, Germany: incidence, clinical subtypes, tumour stages and localization (epidemiology of skin cancer).
Katalinic A; Kunze U; Schäfer T
Br J Dermatol; 2003 Dec; 149(6):1200-6. PubMed ID: 14674897
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of cutaneous melanoma in Germany and worldwide.
Garbe C; Blum A
Skin Pharmacol Appl Skin Physiol; 2001; 14(5):280-90. PubMed ID: 11586069
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology of malignant melanoma in central Europe: risk factors and prognostic predictors. Results of the Central Malignant Melanoma Registry of the German Dermatological Society.
Garbe C; Orfanos CE
Pigment Cell Res; 1992; Suppl 2():285-94. PubMed ID: 1409431
[TBL] [Abstract][Full Text] [Related]
8. Skin melanoma in Saarland: incidence, survival and mortality 1970-1996.
Stang A; Stang K; Stegmaier C; Hakulinen T; Jöckel KH
Eur J Cancer Prev; 2001 Oct; 10(5):407-15. PubMed ID: 11711755
[TBL] [Abstract][Full Text] [Related]
9. Skin cancer mortality in Germany before and after the post-communist transition.
Stang A; Lampert T; Uhlemann T; Trocchi P
Int J Dermatol; 2009 Apr; 48(4):363-70. PubMed ID: 19335420
[TBL] [Abstract][Full Text] [Related]
10. Trends of cutaneous melanoma in The Netherlands: increasing incidence rates among all Breslow thickness categories and rising mortality rates since 1989.
Hollestein LM; van den Akker SA; Nijsten T; Karim-Kos HE; Coebergh JW; de Vries E
Ann Oncol; 2012 Feb; 23(2):524-30. PubMed ID: 21543630
[TBL] [Abstract][Full Text] [Related]
11. Trends of skin cancer in the Canton of Vaud, 1976-92.
Levi F; Franceschi S; Te VC; Randimbison L; La Vecchia C
Br J Cancer; 1995 Oct; 72(4):1047-53. PubMed ID: 7547221
[TBL] [Abstract][Full Text] [Related]
12. Does skin cancer screening save lives? A detailed analysis of mortality time trends in Schleswig-Holstein and Germany.
Stang A; Jöckel KH
Cancer; 2016 Feb; 122(3):432-7. PubMed ID: 26480048
[TBL] [Abstract][Full Text] [Related]
13. Vital signs: melanoma incidence and mortality trends and projections - United States, 1982-2030.
Guy GP; Thomas CC; Thompson T; Watson M; Massetti GM; Richardson LC;
MMWR Morb Mortal Wkly Rep; 2015 Jun; 64(21):591-6. PubMed ID: 26042651
[TBL] [Abstract][Full Text] [Related]
14. Incidence, Mortality, and Trends of Nonmelanoma Skin Cancer in Germany.
Leiter U; Keim U; Eigentler T; Katalinic A; Holleczek B; Martus P; Garbe C
J Invest Dermatol; 2017 Sep; 137(9):1860-1867. PubMed ID: 28487088
[TBL] [Abstract][Full Text] [Related]
15. Increasing time trends of thin melanomas in The Netherlands: What are the explanations of recent accelerations?
van der Leest RJ; Zoutendijk J; Nijsten T; Mooi WJ; van der Rhee JI; de Vries E; Hollestein LM
Eur J Cancer; 2015 Dec; 51(18):2833-41. PubMed ID: 26589973
[TBL] [Abstract][Full Text] [Related]
16. Melanoma epidemiology of Austria reveals gender-related differences.
Duschek N; Skvara H; Kittler H; Delir G; Fink A; Pinkowicz A; Waldhör T
Eur J Dermatol; 2013; 23(6):872-8. PubMed ID: 24184485
[TBL] [Abstract][Full Text] [Related]
17. Incidence, Mortality, and Spatiotemporal Distribution of Cutaneous Malignant Melanoma Cases Across Canada.
Ghazawi FM; Le M; Lagacé F; Cyr J; Alghazawi N; Zubarev A; Roy SF; Rahme E; Netchiporouk E; Roshdy O; Glassman SJ; Sasseville D; Litvinov IV
J Cutan Med Surg; 2019; 23(4):394-412. PubMed ID: 31132871
[TBL] [Abstract][Full Text] [Related]
18. Skin cancer rates in North Rhine-Westphalia, Germany before and after the introduction of the nationwide skin cancer screening program (2000-2015).
Stang A; Jöckel KH; Heidinger O
Eur J Epidemiol; 2018 Mar; 33(3):303-312. PubMed ID: 29294207
[TBL] [Abstract][Full Text] [Related]
19. Trends in malignant melanoma of skin in New Zealand.
Cooke KR; Skegg DC; Fraser J
Int J Cancer; 1983 Jun; 31(6):715-8. PubMed ID: 6862682
[TBL] [Abstract][Full Text] [Related]
20. Incidence, mortality and trends of cutaneous squamous cell carcinoma in Germany, the Netherlands, and Scotland.
Keim U; Katalinic A; Holleczek B; Wakkee M; Garbe C; Leiter U
Eur J Cancer; 2023 Apr; 183():60-68. PubMed ID: 36801607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
